SKAN Group AG Nominates Digital Transformation Expert Dr. Christian Schlogel to Board of Directors

The Board of Directors of SKAN Group AG has proposed Dr. Christian Schlogel as a new member for election at the Annual General Meeting scheduled for May 7, 2026. This nomination follows the decision of Patrick Schar not to stand for re-election after serving 16 years on the board. Dr. Schlogel brings over three decades of leadership experience in global technology, software, and industrial companies, with a focus on digital transformation and artificial intelligence.

From 2018 to 2025, Dr. Schlogel served as Group Chief Digital Officer and a member of the Executive Board at Korber AG, where he led the digital transformation of the group, which employs approximately 14,000 people. Prior to that, from 2014 to 2018, he was Group Chief Technology & Digital Officer at KUKA AG, an international automation and robotics group with around 15,000 employees. He began his career at SAP AG and holds a degree in computer science from the Karlsruhe Institute of Technology and a doctorate in business administration from the University of Passau. Currently, he contributes his expertise as a member of administrative and advisory boards at various companies.

Beat Lüthi, Chairman of the Board of Directors of the SKAN Group, emphasized the strategic importance of this nomination. He stated, "SKAN expands its offering to include software and digital integration services, for which we acquired a majority stake in Metronik last year. In parallel, we are driving forward the digital transformation of the company and our services. Christian Schlögel can significantly support these initiatives, which are core elements of the strategy for future sales and margin growth, with his expertise." This move underscores SKAN's commitment to enhancing its digital capabilities in the pharmaceutical manufacturing industry.

The departure of Patrick Schar marks the end of a significant tenure on the board. Beat Lüthi acknowledged Schar's contributions, noting, "Patrick Schär has been on the Board of Directors for 16 years. With his professional background and experience as a financial expert, he has made a significant contribution to the development of the SKAN Group." The company expressed gratitude for his years of service and wished him well in his future endeavors.

SKAN Group AG, founded in 1968, is a pioneer in aseptic and aseptic-toxic manufacturing processes for the pharmaceutical and biotech industries. As the market and technology leader for high-quality isolator systems used in drug filling under strict sterility standards, the company employs close to 1,700 people globally. Its headquarters are in Allschwil, Switzerland, with subsidiaries in countries including Germany, Belgium, France, Slovenia, Croatia, Japan, the USA, and Brazil. The nomination of Dr. Schlogel aligns with SKAN's ongoing efforts to innovate and adapt to evolving industry demands through digital solutions. For more information, visit https://www.newmediawire.com.